Back

Management and outcome of different types of ventricular tachycardia related to hypokalemia

31 March 2025 (08:00 - 17:45)
Organised by: Logo
Congress Presentation Part of: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Ines Masmoudi

German Heart Center of Munich, Munich (Germany)

146 More presentations in this session

Presentation thumbnail
Impact of ICD and CRT-D implantation on survival in ischemic and non-ischemic cardiomyopathy: a single-center croatian retrospective cohort study and comparative insights with the DANISH trial
Assistant Professor M. Puljevic (Zagreb, HR)
Abstract
Presentation thumbnail
Do the longer leadless pacemakers with helix screws affect tricuspid regurgitation after pacemaker implantation?
Presentation thumbnail
Classification of atrial fibrillation burden pattern in cardiac implantable electronic devices
Mr S. Majumder (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Life-threatening arrhythmia in patients with suspected acute myocarditis
Miss K. Bulatova (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Early outcomes of left bundle branch area pacing upgrade in pediatric pacing-induced cardiomyopathy
Mr Y. Turubayev (Astana, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias

The Event

Event poster

EHRA 2025

31 March 2025 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Ventricular arrhythmias in hypertrophic cardiomyopathy patients: prevalence, distribution, predictors and outcome
23 May 2022
thumbnail
Congress Presentation
What is the treatment and management for patients with hypokalaemia? A critical review of the literature
13 June 2025
thumbnail
Congress Presentation
Management and outcomes of electrical storm: a ten-year single-centre experience comparing early catheter ablation and medical therapy
21 March 2026
thumbnail
ESC Journals
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial
29 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources